1504 The influence of dietary resistant starch content on the gut microbiota of patients with systemic lupus erythematosus and antiphospholipid syndrome
Iryna Kulyk(University of Münster), Martin Kriegel(University of Münster), Daniel F. Zegarra-Ruiz(Carter Center), Teri M. Greiling(Oregon Health & Science University), William Ruff(Yale University), Márcia S. Pereira(University of Münster), Odelya E. Pagovich(Regeneron (United States)), Carina Dehner(Indiana University School of Medicine), Doruk Erkan(Hospital for Special Surgery), Sylvio Redanz(University of Münster), Cassyanne L. Aguiar(Eastern Virginia Medical School)
Cited by 0
Related Papers
Assessment of the 2006 revised antiphospholipid syndrome classification criteria
|Annals of the Rheumatic Diseases|2007|95
Treatment of the Antiphospholipid Syndrome
|New England Journal of Medicine|2003|81
How I treat catastrophic thrombotic syndromes
|Blood|2015|70
Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy
|Blood Advances|2017|69
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay
|Clinical and Molecular Allergy|2016|48